TheraRadar
← Back
Data updated: Jun 28, 2026

CENTRAL RADIOPHARM

Generics
Pharmaceuticals

CENTRAL RADIOPHARM is a generic drug manufacturer with 1 FDA-approved products.

2015
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

CENTRAL RADIOPHARM's Key Drugs

CENTRAL RADIOPHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CENTRAL RADIOPHARM's Recent FDA Approvals

New NDA/BLA approvals for CENTRAL RADIOPHARM over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

CENTRAL RADIOPHARM's Therapeutic Areas

Disease areas where CENTRAL RADIOPHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

CENTRAL RADIOPHARM Pipeline Snapshot

Active clinical trials for CENTRAL RADIOPHARM across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling